Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Yuya Aono"'
Autor:
Noriyuki Enomoto, Hyogo Naoi, Yasutaka Mochizuka, Takuya Isayama, Yuko Tanaka, Atsuki Fukada, Yuya Aono, Mineo Katsumata, Hideki Yasui, Kazutaka Mori, Masato Karayama, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Takafumi Suda
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Acute exacerbation (AE) of systemic autoimmune disease-related interstitial lung diseases (SAID-ILD) is less common than AE of idiopathic pulmonary fibrosis (IPF) and the details of AE-SAID-ILD have not been elucidated, but the pr
Externí odkaz:
https://doaj.org/article/c51e546ed9df475292b3a89b6a3680de
Autor:
Yuzo Suzuki, Kazutaka Mori, Yuya Aono, Masato Kono, Hirotsugu Hasegawa, Koshi Yokomura, Hyogo Naoi, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Hidenori Nakamura, Takafumi Suda
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Antifibrotic therapy (AFT) slows disease progression in patients with idiopathic pulmonary fibrosis (IPF). The Gender-Age-Physiology (GAP) index, was developed based on data at IPF diagnosis before the introduction of AFT and has not been ev
Externí odkaz:
https://doaj.org/article/e4053b1dc1be411488281f1878f5b551
Autor:
Yuzo Suzuki, Kazutaka Mori, Yuya Aono, Masato Kono, Hirotsugu Hasegawa, Koshi Yokomura, Hyogo Naoi, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Hidenori Nakamura, Takafumi Suda
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Currently, there are two antifibrotics used to treat idiopathic pulmonary fibrosis (IPF): pirfenidone and nintedanib. Antifibrotics slow disease progression by reducing the annual decline of forced vital capacity (FVC), which poss
Externí odkaz:
https://doaj.org/article/4dbda5c1c00342a09b5cd06cd44651aa
Autor:
Yuya Aono, Yutaro Nakamura, Masato Kono, Hidenori Nakamura, Koshi Yokomura, Shiro Imokawa, Mikio Toyoshima, Hideki Yasui, Hironao Hozumi, Masato Karayama, Yuzo Suzuki, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Takafumi Suda
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 14 (2020)
Background: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease (ILD). Currently, two antifibrotic drugs are available for reducing forced vital capacity (FVC) decline in IPF. However, many pulmonologists wait bef
Externí odkaz:
https://doaj.org/article/40c21df7cfa044998f4e9b75e870075d
Autor:
Noriyuki Enomoto, Hyogo Naoi, Yuya Aono, Mineo Katsumata, Yasuoki Horiike, Hideki Yasui, Masato Karayama, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Takafumi Suda
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 14 (2020)
Background: Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is well known as a life-threatening condition during its clinical course. However, the clinical features and prognosis in AE of unclassifiable idiopathic interstitial pneumonia
Externí odkaz:
https://doaj.org/article/a83ba1f106eb4532a02c2413af33d001
Autor:
Yuya Aono, Yuzo Suzuki, Ryo Horiguchi, Yusuke Inoue, Masato Karayama, Hironao Hozumi, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Shinji Mii, Masahide Takahashi, Takafumi Suda
Publikováno v:
American Journal of Respiratory Cell and Molecular Biology. 68:201-212
Asthma is a chronic airway inflammatory disease characterized by airway hyperreactivity (AHR) and eosinophilic airway inflammation. Dendritic cells (DCs) are essential for the development of asthma via presenting allergens, causing Th2 skewing and eo
Autor:
Yuya Aono, Hironao Hozumi, Masato Kono, Dai Hashimoto, Hidenori Nakamura, Koshi Yokomura, Shiro Imokawa, Masahiro Shirai, Daisuke Akahori, Yusuke Inoue, Kazutaka Mori, Masato Karayama, Yuzo Suzuki, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Takafumi Suda, Aono, Yuya
Publikováno v:
Thorax; Aug2023, Vol. 78 Issue 8, p825-834, 10p
Autor:
Syuhei Ikeda, Yoshimori An, Moritake Iguchi, Hisashi Ogawa, Yumiko Nakanishi, Kimihito Minami, Kenjiro Ishigami, Yuya Aono, Kosuke Doi, Yasuhiro Hamatani, Takashi Yoshizawa, Yuya Ide, Akiko Fujino, Mitsuru Ishii, Nobutoyo Masunaga, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Masaharu Akao
Publikováno v:
European heart journal. Quality of careclinical outcomes.
Aims Previous studies have shown that proteinuria is independently associated with the incidence of atrial fibrillation (AF), and is also associated with the incidence of cardiovascular events such as stroke and thromboembolism in patients with AF. H
Autor:
Hyogo Naoi, Hironao Hozumi, Kazuki Furuhashi, Noriyuki Enomoto, Naoki Inui, Yutaro Nakamura, Masato Karayama, Yuya Aono, Takuya Isayama, Hideki Yasui, K. Tanaka, Takafumi Suda, Yuzo Suzuki, Tomoyuki Fujisawa, Mineo Katsumata
Publikováno v:
Respiratory Investigation. 59:827-836
Background: Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is a devastating and life-threatening condition during its clinical course. Biomarkers for precisely anticipating the prognosis of AE-IPF remain to be fully established. The obj
Autor:
Yasuhiro Hamatani, Moritake Iguchi, Kenji Moriuchi, Yuta Anchi, Yasutaka Inuzuka, Ryusuke Nishikawa, Kiyotaka Shimamura, Hirokazu Kondo, Hibiki Mima, Yugo Yamashita, Kensuke Takabayashi, Kotoe Takenaka, Kengo Korai, Yuichi Kawase, Ryosuke Murai, Hidenori Yaku, Kazuya Nagao, Mariko Kitano, Yuya Aono, Takeshi Kitai, Yukihito Sato, Takeshi Kimura, Masaharu Akao
Publikováno v:
BMJ Supportive & Palliative Care. :spcare-2023
ObjectivesMorphine is effective in alleviating dyspnoea in patients with cancer. We aimed to investigate the effectiveness and safety of morphine administration for refractory dyspnoea in patients with advanced heart failure (HF).MethodsWe conducted